You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Buy Disclosure
Jahr Robert Charles · SEC Form 4 · Filed Aug 14, 2026
Buy
Reported value range
Not reported
Jahr Robert Charles Chief Executive Officer
OTLK
Outlook Therapeutics
OTLK
Transaction date
Aug 14, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed same day
OTLK daily price context
Close on/before transaction
$0.76
Aug 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Warrants (right to buy) on Common Stock
- Quantity / price
- 151,515 shares
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-097406
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
Not reported
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK | Buy | Aug 14, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK Current | Buy | Aug 14, 2026 | Not reported |